Molecular Pharmacology

Research Frontiers in Histone Deacetylase Isoform Selective Inhibition

Development of HDAC inhibitors with selectivity for specific isoforms to achieve therapeutic benefit while minimizing pan-HDAC toxicity in cancer and neurological disease.

All Molecular Pharmacology PhD categories